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Background: The C452F mutation in the mitochondrial fission protein Drp1 leads to heart failure through an unknown
mechanism.
Results: C452F impairs Drp1 disassembly, leading to impaired mitophagy, failed bioenergetics, and inflammation.
Conclusion: Drp1-mediated mitochondrial fission is essential for normal cardiac function.
Significance:Mutations in mitochondrial quality control proteins are a likely cause of human cardiomyopathy.
We have reported previously that a missense mutation in the
mitochondrial fission gene Dynamin-related protein 1 (Drp1)
underlies the Python mouse model of monogenic dilated car-
diomyopathy. The aim of this study was to investigate the con-
sequences of the C452Fmutation on Drp1 protein function and
to define the cellular sequelae leading to heart failure in the
Python monogenic dilated cardiomyopathy model. We found
that the C452F mutation increased Drp1 GTPase activity. The
mutation also conferred resistance to oligomer disassembly by
guanine nucleotides and high ionic strength solutions. In a
mouse embryonic fibroblast model, Drp1 C452F cells exhibited
abnormal mitochondrial morphology and defective mitophagy.
Mitochondria in C452F mouse embryonic fibroblasts were
depolarized and had reduced calcium uptake with impaired
ATP production by oxidative phosphorylation. In the Python
heart,we founda correspondingprogressivedecline inoxidative
phosphorylation with age and activation of sterile inflamma-
tion. As a corollary, enhancing autophagy by exposure to a pro-
longed low-protein diet improved cardiac function in Python
mice. In conclusion, failure of Drp1 disassembly impairs
mitophagy, leading to a downstream cascade of mitochondrial
depolarization, aberrant calcium handling, impaired ATP syn-
thesis, and activationof sterilemyocardial inflammation, result-
ing in heart failure.
Dilated cardiomyopathy (DCM)6 is a heart failure syndrome
characterized by progressive cardiomyocyte loss, contractile
dysfunction, and sudden death. Its etiology is diverse, including
ischemia, inflammation, and genetic disease (1). Rare mono-
genic forms of DCM are mechanistically tractable models,
yielding insights into disease pathogenesis. For example, energy
deficiency is a common, albeit typically late, feature ofDCM(2).
Understanding the cellular regulation of mitochondria and
control of energetics is of fundamental importance for develop-
ing novel therapies.
We have reported previously that the C452Fmutation in the
gene encoding the mitochondrial fission protein Dynamin-re-
lated protein 1 (Drp1, also known as Dnm1l) causes DCM in
mice (3). Mitochondrial morphology and function are regu-
lated dynamically by conserved fission and fusion proteins.
Drp1, a member of the dynamin superfamily of large GTPases,
is the principal mitochondrial fission protein in eukaryotic
cells. After activation, Drp1 translocates from a cytosolic pool
to the outer mitochondrial membrane, where it oligomerizes,
hydrolyzes GTP, and constricts to divide mitochondria (4).
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Mitochondrial remodeling has multiple roles, including
quality control and clearance of mitochondria by mitophagy,
segregation of mitochondrial DNA and proteins, and apoptosis
(5). As a corollary, Drp1 contributes to Parkin-induced
mitophagy inMEFs (6). Changes inmitochondrial morphology
reflect active cellular control over mitochondrial function. For
example, mitochondrial elongation under conditions of nutri-
ent deprivation protects against mitophagic degradation and
preserves ATP synthesis (7, 8) Failure of cellular control over
mitochondria triggers inflammation by Toll-like receptors or
the inflammasome, leading to heart failure (9, 10).
A single human mutation in DRP1 has been identified
(A395D), lying close to the C452F mutation in the middle
domain of the protein (11). DRP1 A395D is lethal in infancy,
causing abnormal development, lactic acidosis, and encepha-
lopathy. Biochemically, the mutant A395D protein has been
found to be defective for self-assembly andGTPhydrolysis (12).
Here we show that the C452Fmutation inDrp1 dysregulates
protein disassembly. In a MEF model, this results in abnormal
mitochondrial morphology, mitophagy, mitochondrial mem-
brane potential, and calcium signaling. In the hearts of Drp1
C452F (Python) mice, there is a corresponding progressive
decline in oxidative phosphorylation and activation of sterile
inflammation. Prolonged exposure of Python mice to a low-
protein diet augments intrinsic cellular macroautophagy and
improves cardiac function.We conclude that, in the heart, fail-
ure of Drp1-mediated mitochondrial regulation leads to
impairment of mitophagy, bioenergetic failure, and inflamma-
tion, ultimately resulting in DCM.
Experimental Procedures
Animal Studies—Drp1 C452F mice (Python) have been
described previously (3). Procedures involving live animals
were performed in line with United Kingdom Home Office
guidelines (project license 30/2977). Unless stated otherwise,
mice were backcrossed onto a C57BL/6 genetic background for
at least five generations. Where indicated, mice were fed an
isocaloric 6% low-protein diet (Teklad TD.90016 diet, Harlan
Teklad) from 4 weeks of age onwards.
Mouse Embryonic Fibroblasts—Drp1 C452F MEFs were
derived from embryonic day 13.5 embryos. Cells were cultured
in Dulbecco’s modified Eagle’s medium supplemented with
10% fetal bovine serum and immortalized using SV40 large T
antigen. Transient transfections were performed using Lipo-
fectamine 2000 (Invitrogen) according to the protocol of the
manufacturer. Where indicated, MEFs were transfected and
imaged by confocal microscopy as described previously (13).
Drp1/MEFs (14) were originally a gift from Prof. Mihara to
Prof. Scorrano. For starvation experiments, MEFs were washed
four times and then incubated in Hanks’ balanced salt solution
supplemented with 10 mM HEPES (pH 7.4) at 37 °C for the
indicated time.
Mitochondrially Targeted, Photoactivatable GFP (mito-
PAGFP) Imaging—MEFs were cotransfected as above with
mito-PAGFP (Addgene) and dsRed. After focal activation of
mitochondria, whole cells were imaged by confocal micros-
copy at 5, 10, and 30 min, and the fluorescence intensity of
the mito-PAGFP signal in the photoactivated region was
plotted against time. Values of the percentage of mito-
PAGFP fluorescence decrease in the region of activation
were plotted against time for each experimental group as
described previously (15).
DNA Constructs for Protein Expression—For protein expres-
sion, Drp1 isoform 1 (GenBank accession no. AB006965) was
amplified by PCR with Pfu Turbo DNA polymerase (Strat-
agene) as an NdeI/XhoI fragment, with a tobacco etch virus
protease site (ENLYFQS) preceding the XhoI restriction site.
The resulting DNA fragment was then ligated into the bacterial
expression vector pET29b (EMD Millipore, Billerica, MA),
which contains a C-terminal His6 tag. The C452F and A401D
mutations were introduced into pET29b-Drp1-His6 using the
QuikChange method (Stratagene). All constructs were verified
by DNA sequencing (Retrogen).
Expression and Purification of His6-tagged Drp1, Drp1
C452F, and Drp1 A401D—Drp1 activity was evaluated by
recombinant expression of the human enzyme isoform1,which
shares 94.5% sequence identity with mice. The human muta-
tion A395D is equivalent to mouse A401D. For expression of
His6-tagged Drp1, C452F-His6, and A401D-His6 fusion pro-
teins, plasmids were transformed into Escherichia coli BL21
(DE3). Cells were grown at 37 °C in Super Broth with kanamy-
cin (30 g/ml) to an A600 of1.5 with shaking at 250 rpm. The
temperature was lowered to 14 °C, and, after 30 min, protein
expression was induced with 0.5 mM isopropyl 1-thio--D-ga-
lactopyranoside for 12–16 h. Cells were harvested by centrifu-
gation using a Sorvall JLA-8.1000 rotor at 5000 rpm for 10 min
at 4 °C and resuspended in column buffer A (20mMHEPES (pH
7.4), 400 mM NaCl, 5 mM MgCl2, and 40 mM imidazole) con-
taining protease inhibitors (Complete, EDTA-free protease
inhibitor mixture, Roche Applied Science). Cells were lysed by
five passes through Emulsiflex C-3 (Avestin) operating at
15,000 p.s.i. DNase was added to a final concentration of 1
g/ml, and lysates were clarified by centrifugation using a Sor-
vall SS34 rotor at 15,000 rpm for 30 min at 4 °C. His6-tagged
fusion proteins were isolated from the resulting supernatant by
affinity chromatography using Ni2-Sepharose high-perfor-
mance beads (GE Healthcare). Bound fusion proteins were
washedwith 200–300ml of column buffer A, 100ml of column
buffer B (20mMHEPES (pH7.4), 400mMNaCl, 5mMMgCl2, 40
mM imidazole, 1 mM ATP, and 10 mM KCl), 100 ml of column
buffer C (20 mM HEPES (pH 7.4), 40 mM imidazole, 400 mM
NaCl, 0.5% (w/v) CHAPS), and 100 ml of column buffer A.
Bound fusion proteins were then eluted with column buffer D
(20 mM HEPES (pH 7.4), 400 mM NaCl, 5 mM MgCl2, and 500
mM imidazole). Fractions containing His6-tagged Drp1 were
pooled and dialyzed overnight at 4 °C into buffer containing 20
mM HEPES (pH 7.4), 5 mM MgCl2, and 400 mM NaCl with
Fisherbrand regenerated cellulose dialysis tubing with a 6000–
8000 molecular weight cutoff (Thermo Fisher Scientific). Pro-
teins were concentrated by centrifugation in Vivaspin 20 ultra-
filtration devices with a 50,000 molecular weight cutoff (GE
Healthcare). Drp1 concentration was quantified by UV absor-
bance at 280 nm using an extinction coefficient of 36380 M1
cm1 after incubation for 1 h in 6 M guanidine hydrochloride at
65 °C. Purified protein was stored at 4 °C until use and used
within 36 h of cell lysis or frozen in 1-ml aliquots using a dry ice
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and ethanol bath. Frozen aliquots were stored at 80 °C and
showed no loss of activity compared with fresh protein when
used within 12 h of thawing.
GTPase Activity Assay—A continuous GTPase assay was
used in which the rate of GTP hydrolysis was determined
through coupling to a GTP regeneration system as described
previously (12). GTPase activity was assayed in 150 l of
GTPase reaction buffer (25 mM HEPES, 25 mM PIPES, 7.5 mM
KCl, 5 mM MgCl2, 1 mM phosphoenolpyruvate, 20 units/ml
pyruvate kinase/lactate dehydrogenase, and 600 M NADH
(pH 7.0)), which was placed into the wells of a 96-well flat,
clear-bottom plate. Depletion of NADH over time was mea-
sured for 40 min at 25 °C at indicated GTP, enzyme, and NaCl
concentrations by using a Molecular Devices Flexstation 3
multi-detection reader with integrated fluid transfer. GTPase
assays were started by the addition of GTP to the desired con-
centration. Substrate kinetics at each indicated NaCl concen-
tration were measured but did not achieveVmax at higher NaCl
concentrations. For this reason, we report kobs at 1 mM GTP.
For the determination of salt dependence, the final NaCl con-
centration varied between 50 and 500mM as indicated, whereas
enzyme concentrations were held at 2.5 M. Enzyme activity
was alsomeasured in the presence of ATP as a substrate, but no
measurable activity was observed.
Drp1 Light-scattering Assay—To assess the relative assembly
and disassembly of Drp1 and mutations, the known NaCl depen-
dence on Drp1 assembly/disassembly was measured by moni-
toring the light-scattering signal at 450 nm during the course of
the continuous GTPase assay by robotic addition of 100 l of
reaction buffer with 0, 150, or 525 mM NaCl concentration to
give a final [NaCl] of 90, 150, or 300 mM, respectively. Added
buffers contained 1 mM GTP and the coupled reagents as
described above. The linear range of these data, typically over
an 8-min window, were fit to a straight line, with the resulting
slope normalized for total protein and reported as the A450
min1 mg of enzyme1.
Western Blotting—Standard protocols were utilized.
Briefly, tissue lysates were obtained following homogeniza-
tion in radioimmune precipitation assay buffer (50 mM Tris-
HCl, 150 mMNaCl, 2 mM EDTA, 1%Nonidet P-40, 0.1% SDS,
and 1% sodium deoxycholate) containing protease inhibi-
tors, separated by SDS/PAGE, and transferred onto a PVDF
membrane. The antibodies used were anti-LC3 (Cell Signal-
ing Technology), anti--tubulin (Sigma-Aldrich), anti-Opa1
(Cell Signaling Technology), and anti-Mfn1 and anti-Mfn2
(Abcam).
Cloning—Drp1-YFP was mutated to Drp1-C452F YFP by a
PCR-basedmethod, and themutationwas confirmed by Sanger
sequencing.
RNA Preparation and Quantitative PCR—RNA was ex-
tracted fromharvested hearts usingTRIzol reagent, followed by
RNA cleanup using the RNeasy kit (Qiagen) according to the
instructions of the manufacturer. 2 g of RNA was used to
generate cDNA using a high-capacity cDNA synthesis kit
(Applied Biosystems). IL-6, IFIT-1, TNF, and IFN primer/
probe sets were obtained from Applied Biosystems. mRNA
expressionwas determined by quantitative real-timePCRusing
TaqMan Fast Universal PCRMaster Mix (Applied Biosystems)
on a 7900 fast real-time PCR system machine (Applied Biosys-
tems). Data were analyzed according to the Ct method, with
hypoxanthine-guanine phosphoribosyltransferase serving as
the reference housekeeping gene.
Mitochondrial:Nuclear DNA Ratio—DNA was extracted
from powdered ventricular myocardium using the DNeasy
blood and tissue kit (Qiagen) according to the instructions of
the manufacturer. The ratio of mitochondrial ND1 to nuclear
NDUFV1 was calculated by quantitative PCR using the follow-
ing primers/probe sets:Mt-NDP1 forward, TCGACCTGACA-
GAAGGAGAATCA; MT-ND1 reverse, GGGCCGGCTGCG-
TAT; MT-ND1 probe, AATTAGTATCAGGGTTTAACG;
Nuc-Ndufv1 forward, GAGCAGGACTTCTCCTTCACATC;
Nuc-Ndufv1 reverse, CCCGTCTCAGGGCACCTT; and Nuc-
Ndufv1 probe, TTTCCTACTCTGTCCAGGCT.
Mitochondrial Membrane Potential—MEFs were cultured
on coverslips in growth medium until 80% confluent. The cells
were then incubated in a final concentration of 2 M JC-1
(Invitrogen) for 30min at 37 °C, 5%CO2. Images were captured
using a Zeiss LSM 5.10 confocal microscope. Fluorescence was
quantified using ImageJ 1.42q software.
ATP Levels—Cells were harvested and washed twice in 1 ml
of incubation medium (140 mM NaCl, 5 mM KCl, 1 mM MgCl2,
1.2 mM CaCl2, 6 mM glucose, 20 mM sodium-HEPES (pH7.4),
and 0.04% phenol red). After the final wash, cells were resus-
pended in 70 l of permeabilizing solution (30 M digitonin,
140 mM potassium glutamate, 1 mM EGTA, 1 mMMgCl2, 6 mM
glucose, 20 mM potassium-PIPES (pH 7.0), and 0.04% phenol
red) and incubated for 10 min at 30 °C. Each cell line was ana-
lyzed in triplicate, with volumes of 20 l aliquoted into three
wells of a white 96-well plate. 180 l of the standard reaction
solution (1 M DTT, 0.5 mM D-luciferin, and 12.5 M firefly
luciferase (Invitrogen)) was added to the cells in suspension.
Luciferase activity was measured using the Berthold Mithras
LB940 system with Mikrowin 2000 software. A standard curve
of known ATP concentrations against luminescence was used
to deduce ATP concentrations.
Mitochondrion-LC3 Colocalization—Cells were seeded on a
96-well plate. The next day, the medium was changed, and
either bafilomycin (10 nM) or dimethyl sulfoxide vehicle was
added for incubation overnight. Three replicates of each treat-
ment were performed. Following fixation in 4% paraformalde-
hyde, cells were incubated with a primary mouse monoclonal
antibody to pyruvate dehydrogenase (1:200, MSP03, Cam-
bridge Bioscience) and a primary rabbit monoclonal antibody
to LC3 (1:1000, PM036, Caltag-Medsystems Ltd.) for 1 h at
room temperature. Cells were then washed three times with
PBS before incubation with rabbit Alexa Fluor 488-conjugated
secondary antibody (1:500, Invitrogen) and mouse Alexa Fluor
546-conjugated secondary antibody (1:500, Invitrogen) for 40
min at room temperature. Cells were again washed three times
with PBS for 5 min before DAPI staining, at 0.5 g/ml diluted
with PBS, for 5 min. DAPI was replaced with PBS before foci
were detected using an INCell Analyzer 1000 automated epifluo-
rescence microscope (GE Healthcare). 8–12 images (200 cells)
were obtained per well. The immunofluorescence signal was
quantified using IN Cell Analyzer workstation software (ver-
sion 3.5). Mitophagy was measured by colocalization of mito-
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chondrial and LC3 signals as the number of colocalizing LC3-
positive puncta.
Calcium Studies—Cells were perfused with 2.5 mM Ca2-
containing buffer, followed by Ca2-free buffer containing 1
mM EGTA for the duration indicated by the clear horizontal
bar. For the CPA/oligomycin experiment, cells were initially
perfused with 2.5 mM Ca2-containing buffer and then
switched to Ca2-free buffer containing 1 mM EGTA for the
duration marked by the clear horizontal bar. 10 M CPA was
applied for the duration shown by the horizontal black bar.
Mitochondrial Ca2 stores were emptied by applying 10 M
carbonyl cyanide p-trifluoromethoxyphenylhydrazone (FCCP)
to collapse the mitochondrial membrane potential in the pres-
ence of 2.5 g/ml oligomycin. CPA was still present in the per-
fusate when FCCP and oligomycin was applied to prevent
reuptake of Ca2 into the endoplasmic reticulum. A similar
protocol was used to measure cytosolic Ca2 following the
application of 0.1 mM ATP to deplete intracellular Ca2 stores.
Mitochondrial Ca2 concentration was measured following
transfection of a mitochondria-targeted aequorin using Lipo-
fectamine 2000 (Invitrogen).Wild-type and PythonMEFs were
washed twice in Krebs-Ringermodified buffer (125mMNaCl, 5
mM KCl, 1 mM Na3PO4, 1 mM MgSO4, 5.5 mM glucose, and 20
mM HEPES (pH 7.4)) containing 1 mM CaCl2 and then incu-
bated in Krebs-Ringer modified buffer containing 1 mM CaCl2
and 5 M coelenterazine (Promega) for 30 min on ice to recon-
stitute the aequorin protein. Following a final centrifugation,
cellswere resuspended in 90l of Krebs-Ringermodified buffer
containing 1mMCaCl2 and 5M coelenterazine. The cells were
then transferred to a white 96-well plate. Luminescence was
measured every 0.5 s using the Berthold Mithras LB940 system
with Mikrowin 2000 software. After 30 s, tert-butylhydroqui-
none was added to the cells to a final concentration of 10 mM.
Subsequent conversion to Ca2 concentration was achieved
using a standard curve of known Ca2 concentrations against
luminescence.
Transthoracic Echocardiography—Mouse echocardiography
was performed as described previously (16). Briefly, mice were
anesthetized lightly using 1–1.5% isoflurane and imaged with a
22- to 55-MHz linear array transducer using the Vevo 2100
ultrasound system (Visualsonics). M mode tracings of short-
axis images were obtained via the left parasternal window and
used to measure the left ventricular end-diastolic chamber
dimension and end-systolic chamber dimensions and the ante-
rior and posterior wall thickness on the basis of measurements
averaged from at least three cardiac cycles.
Transverse Aortic Constriction—Male C57Bl/6J mice (body
weight, 25 g) underwent transverse aortic constriction or
sham surgery. Briefly, mice were anesthetized with isoflurane
and intubated and underwent trans-sternal thoracotomy. The
transverse aorta was constricted with a 7-0 polypropylene
monofilament suture (Ethicon) tied against a 27-gauge needle.
In sham-operated mice, the aortic arch was dissected, but no
suture was tied. Mice were given subcutaneous buprenorphine
0.8 mg/kg) for pain relief and overnight heat therapy to mini-
mize surgery-induced hypothermia. All mice underwent echo-
cardiography at 4–6 weeks to confirm left ventricular dysfunc-
tion prior to tissue harvest.
TissueHarvesting—Allmicewereweighed and euthanized by
cervical dislocation. The heart was excised, washed briefly with
ice-cold PBS, blotted, and weighed before snap-freezing in liq-
uid nitrogen and storage at80 °C.
Oxidative Phosphorylation (OXPHOS)—Heart tissue was
excised from Python and wild-type mice at various ages and
placed directly in Mir05 solution (0.5 mM EGTA, 3 mM
MgCl26H2O, 60mMpotassium-lactibionate, 20mM taurine, 10
mM KH2PO4, 20 mM HEPES, 110 mM sucrose, and 1 mg/ml
BSA) on ice to preserve mitochondrial function. The tissue was
then teased apart under themicroscope into very fine segments
and placed in 50 g/ml saponin on ice for 30min to lyse cells and
expose the mitochondria. The saponin was then removed by
three subsequent washes inMir05 and placed into the chamber
of the OROBOROS Oxygraph-2K. Although O2 flux was mea-
sured constantly, 10 mM pyruvate, 2 mM malate, and 10 mM
glutamate were added to show total respiration. Complexes V
and II were assessed with the addition of 2.5 mM ADP and 10
mM succinate, respectively. FCCP was added gradually from
0.5–1.25M to completely uncoupleO2 consumption andATP
production, indicating the maximum capacity of OXPHOS.
The complex I inhibitor rotenone was added at 0.5 M. Finally,
the addition of 2.5 M antimycin A, a complex III inhibitor,
completely terminated the process of OXPHOS, and any
remaining O2 consumption at this stage occurred by non-mi-
tochondrial respiration.
Transmission Electron Microscopy—Tissue for electron
microscopy was processed as described previously (17). To
count autophagosomes by EM, only structures that were dou-
ble-membraned, spatially distinct (i.e. separated from other
organelles such as mitochondria, suggesting mature autopha-
gosomes), and had cytosolic content were included in the anal-
ysis. Where indicated, MEFs were incubated with bafilomycin
A (500 nM, Sigma).
Statistics—All data are expressed as mean  S.E. Statistical
analysis was performed using unpaired Student’s t test or anal-
ysis of variance followed by Bonferroni correction where
appropriate. Statistical analysiswas carried out usingGraphPad
Prism version 6. Differences were considered statistically sig-
nificant when p 0.05.
Results
The C452F Mutation Impairs Disassembly of Drp1 Olig-
omers—The Drp1 C452F mutation underlying the Python
DCM model lies in close proximity to the reported human
A395Dmutation, labeled here as (murine position)A401D (Fig.
1A). We suspected similar mechanisms of protein dysfunction,
namely interferencewithDrp1 self-association andGTPhydro-
lysis. We measured GTP hydrolysis by Drp1 C452F compared
with wild-typeDrp1 and the assembly-deficientmutationDrp1
A401D.Unexpectedly, we found that theDrp1C452Fmutation
stimulates GTP hydrolysis (Fig. 1B). Because both Drp1 assem-
bly and activity are known to be salt-dependent (where high
[NaCl] favors disassembly), we compared the activity of the
C452F mutant protein with the wild type under varying salt
conditions. We found that GTP hydrolysis by Drp1 C452F is
less sensitive to [NaCl] than the wild type, with supranormal
GTP hydrolysis at all concentrations (Fig. 1C).
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We hypothesized that, given the linkage between Drp1
hydrolytic activity and assembly state, the Drp1 C452F mutant
may also exhibit an increase in higher-ordered assembly. Pro-
tein assembly was measured by light scattering at 450 nm, and
Drp1 was indeed shown to be more assembled by this measure
comparedwithWTenzymeor theA401Dmutant (2.5Mprotein,
data not shown). To test whether this observation was caused by
an inability of the mutant to properly disassemble because of a
stabilization of the higher-ordered oligomeric state, we sought to
observe Drp1 disassembly in real time. In reactions containing 10
Mprotein (wild-typeormutant) and150mMNaCl, assemblywas
allowed to progress for 20 min after starting the reactions with 1
mMGTP.After20minof reaction time,buffers that altered the salt
concentration of the reaction were added to measure the overall
effectonassembly.TheC452Fmutant showsa significant increase
in light scattering compared with the wild type (Fig. 1D), con-
sistent with increased assembly. We found that, with increas-
ing [NaCl] promoting disassembly, there is a persistently high
light-scattering signal from the C452F mutant compared with
theWT and A401D (Fig. 1E). Overall, these data show that the
FIGURE 1. A, structure of the Drp1 protein. The C452F mutation identified in the Python mouse model of DCM lies in close proximity to the reported
human A395D (equivalent to mouse A401D) mutation in the middle domain. VD, variable domain; GED, GTPase effector domain. B, the Drp1 C452F
mutation stimulates GTP hydrolysis comparedwithwild-type Drp1 and the assembly-deficientmutation Drp1 A401D. C, the C452Fmutation impairs the
NaCl dependence of GTP hydrolysis observed with wild type Drp1. D, assembly was measured via absorbance at 450 nm in reactions containing 20 M
Drp1WT, 10MDrp1 A401D, or 10MDrp1 C452F. Reactions were started by the addition of 1mMGTP. After 20min of reaction time, buffers that altered
the salt concentration of the reactionwere added tomeasure the overall effect on assembly at final [NaCl] of 90mM, 150mM, and 300mM. Representative
data at [NaCl]final 300 mM. E, light-scattering at varying [NaCl], showing a persistently high signal from the C452F mutant compared with the WT and
A401D, consistent with failure of disassembly. F, to visualize the distribution of Drp1 C452F, Drp1/MEFs were transfected with a YFP-tagged Drp1WT
or Drp1 C45F construct. Drp1 C452F is seen in cytosolic clumps, consistent with increased assembly, in contrast to the diffuse cytosolic pattern of Drp1
WT.
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C452F mutation impairs protein disassembly after oligomeri-
zation with futile GTP hydrolysis.
To assess the effect of themutation on the distribution of cellular
Drp1,wetransfectedDrp1/MEFswith theDrp1WTconstructor
theC452Fmutant taggedwithYFP. In keepingwith the biochemical
evidence of a failure of disassembly, Drp1 C452F-YFPwas aggregat-
edandclumpedwithincells rather thanbeingdistributedthroughout
the cytosol, as seen in theDrp1WT-YFP cells (Fig. 1F).
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Mitochondria in Drp1 C452FMEFs AreMorphologically and
Functionally Abnormal—Assessment of mitochondrial fission-
fusion in the heart is challenging, possibly because of relative
low event frequency or constraints onmitochondrial morphol-
ogy imposed by the “sardine tin” architecture of the cardiomyo-
cyte (11, 18, 19). Accordingly, we generated an immortalized
Drp1 C452F MEF cell line to characterize the effect of the
mutation on mitochondrial morphology and function.
Drp1/MEFs are known to exhibit abnormalities of mito-
chondrial morphology, with highly interconnected networks of
mitochondria (11, 14). As anticipated, we found that the mito-
chondrial morphology in Drp1 C452F MEFs was also grossly
abnormal, with a large increase in the percentage of cells dis-
playing an elongated, interconnected mitochondrial network
(Fig. 2A). This suggests that the C452F mutation leads to a
reduction in mitochondrial fission, with unopposed fusion
driving an interconnected, tubular phenotype.
To exclude a significant contribution from altered levels of
mitochondrial fusion proteins in the elongated mitochondrial
phenotype, we assessed the levels of Mfn1, Mfn2, and Opa1
by Western blot analysis. Levels of Mfn1 and Mfn2 were
unchanged in C452F cells, and levels of Opa1 increased,
although we did not consider this change sufficient to explain
the dramatic phenotype observed (Fig. 2B).
To further study the connectivity of the mitochondrial net-
work, we transfected Drp1 C452F MEFs with a mito-PAGFP
construct as described previously (15). After targeted photoac-
tivation of a region of interest, redistribution of the photoacti-
vated GFP protein can be tracked over time as it disperses
within the mitochondrial network. The rate of decrease of the
GFP signal within the photoactivated region of interest, as it
disperses, is a marker of mitochondrial connectivity. We found
that the mito-PAGFP signal in Drp1 C452F MEFs dispersed
significantly faster than Drp1 WT MEFs, confirming a highly
fused and functionally interconnected mitochondrial network
(Fig. 2C).
Drp1 is required for mitophagy (8). By quantifying the colo-
calization of mitochondrial pyruvate dehydrogenase with GFP
tagged to themature autophagosomalmarker LC3, we assessed
mitophagy at baseline and after exposure to bafilomycin (an
inhibitor of the vacuolar-type proton ATPase), which inhibits
degradation of the late autophagosome. We found a reduction
in mitochondrion-autophagosome colocalization in both Drp1
C452F and Drp1/MEFs compared with the wild type, sug-
gesting impaired mitophagy (Fig. 2D).
In Drp1/ MEFs, there is reduced autophagic clearance
of mitochondria under starvation conditions, suggestive of
impaired mitophagy (8). We assessed whether the mitochon-
dria in Drp1 C452F MEFs were resistant to autophagic clear-
ance. After induction of generalized autophagy through nutri-
ent deprivation, Drp1 WT MEFs showed a significant
reduction in the mitochondrial:nuclear DNA ratio after 10 h,
consistent with mitochondrial degradation by mitophagy,
which was not seen in Drp1 C452F cells (Fig. 2E).
By electron microscopy, starvation in Drp1 WT MEFs trig-
gered the formation of numerous complex autophagosome
structures and vacuoles with multiple membranes (Fig. 2G, i
and ii). In Drp1 C452F MEFs, there were fewer mature
autophagosomes in the cytosol (Fig. 2G), but we observed
numerous small autophagosomes in close apposition with
mitochondria (Fig. 2G, iii and iv). We hypothesize that these
may represent the attempted ingestion of mitochondria into
early autophagosomes. Supramaximal stimulation of general-
ized autophagy by combining starvation with bafilomycin A1
incubation, which blocks autophagosome-lysosome fusion,
stimulated the normal formation of multiple large autophago-
somes, suggesting no primary defect with autophagy in Drp1
C452F MEFs (Fig. 2H).
Overall, these data are consistent with a specific defect in the
clearance of mitochondria by the autophagosomal degradation
pathway. We hypothesized that inefficient clearance of mito-
chondria results in the accumulation of inefficient, damaged
mitochondria, consistent with the increase in mitochondrial
DNA identified previously in the failing Python heart (3).
Indeed, Drp1 C452F mitochondria were depolarized, as mea-
sured by JC1 fluorescence, and produced lower levels of ATP
(Fig. 2, I and J).
The Python Heart Shows an Age-related Decline in OXPHOS
Efficiency—OXPHOS is central to ATP synthesis and is essen-
tial for normal cardiomyocyte function. Because dysfunction of
mitochondrial fission-fusion proteins has been linked to
reduced OXPHOS capacity, we hypothesized that energy defi-
ciency resulting from impaired OXPHOS contributes to DCM
in Python (20, 21).
FIGURE 2. A, representative confocal microscopy images of Drp1 C452F and Drp1 WT MEFs after transfection with mitochondrial red fluorescent protein to
showmitochondria. C452F leads to anelongated, tubular, and interconnectedmitochondrialmorphological phenotype. Cell population analysis ofmitochon-
drial morphology confirms a significant shift to an elongatedmitochondrial morphology (50 cells/experiment; n 3; ***, p 0.001). B, Western blots of Drp1
C452F andWT lysates for keymitochondrial fusion proteins. Levels of Mfn1 andMfn2 were unchanged. Levels of Opa1 were increasedmildly (three indepen-
dent experiments). C, Drp1 C452F and WT MEFs were cotransfected with mito-DsRed and mito-PAGFP for imaging the functional connectivity of the mito-
chondrial network. After activation of GFP in randomly selected regions of interest (circled), the spread of the GFP signal through the highly interconnected
mitochondrial network of Drp1 C452F MEFs was evident by 10 min. This was associated with a drop in GFP fluorescence intensity in the original region of
interest. In contrast, in Drp1 WT MEFs, the reduction in GFP signal in the region of interest was significantly less, indicating reduced connectivity (n	10
cells/group, with 1–2 regions of interest/cell; *, p 0.05). D, autophagosome LC3 and mitochondrial pyruvate dehydrogenase were stained by immunofluo-
rescence and colocalization assessed on an IN Cell Analyzer 1000 automated epifluorescence microscope. Drp1 C452F and Drp1/ MEFs displayed mito-
chondrial-autophagosome colocalization after inhibition of autophagosome degradation by bafilomycin (Baf), ***, p 0.001. E, quantitative PCR analysis of
mitochondrialMT-ND1DNAnormalized tonuclearNDUFV1DNA inMEFs exposed tonutrient deprivation (culture inHanks’ balanced salt solution) for the time
shown (n  3; *, p  0.05; ns, not significant). In WT but not C452F MEFs, nutrient deprivation results in a drop in mitochondrial DNA consistent with
mitochondrial degradation bymitophagy. This decrease is not seen in theDrp1C452F cells. F, after 4 h of nutrient deprivation, C452FMEFs form fewermature,
spatially separated autophagosomes, as counted by EM (20 cells/group, n 3). G, large numbers of smaller autophagosomes are present in close apposition
to mitochondria in Drp1 C452F cells, possibly consistent with stalled ingestion of mitochondria within autophagosomes (arrows). MV, multiple-membraned
vesicles; G, Golgi body;Mi, mitochondrion; N, nucleus. Scale bars 500 nm. H, representative EM image of MEFs after combined nutrient deprivation and 500
nMbafilomycinA1 treatment for 4 h, showingnormal activationof generalizedmacroautophagy after supramaximal stimulation,with diffuse autophagosome
formation in the cytosol. Scale bars 2m. I, ATP concentrationmeasured by firefly luciferase reporter luminescence. **, p 0.01. J, mitochondrialmembrane
potential measured by JC1 fluorescence in Drp1 WT compared with C452F MEFs. ***, p 0.001.
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The efficiency of OXPHOS enzyme complexes was mea-
sured in Python cardiac tissue samples in a respirometer with
specific substrates and inhibitors (Fig. 3A). Between 3 and 5
months of age, we observed a progressive and profound
decrease in the overall level of mitochondrial respiration in the
Python heart, not seen in the wild-type heart (Fig. 3B). This
severe reduction in OXPHOS is likely to be initiated by
decreased activity of ATP synthase at 4months of age, followed
by a reduction in complex I and II activity at 5 months of age,
and then complex III activity at 6 months. These changes
immediately precede the onset of overt heart failure, which
occurs at approximately 6 months of age (3).
Drp1 C452F Alters Mitochondrial and Cytosolic Calcium
Transients—Mitochondrial calcium uptake is intrinsically
linked with the regulation of oxidative metabolism (13, 22–25).
The mitochondrial membrane potential is the major driving
force for calcium uptake across the inner mitochondrial mem-
brane, which, in turn, activates calcium-dependent enzymes of
the Krebs cycle (26). MEFs are well established as a cellular
model to probe the interaction of mitochondrial fission-fusion
dynamics and calcium signaling (27). Knowing that the mito-
chondrial membrane potential and OXPHOSwere impaired in
C452F cells and Python hearts, we characterized both mito-
chondrial and cytosolic calcium transients in Drp1 C452F
MEFs.
First, we exposed cells to cyclopiazonic acid (CPA), an inhib-
itor of the endoplasmic reticulum (ER) Ca2 ATPase. Follow-
ing store depletion, we added FCCP together with oligomycin
(to prevent ATP consumption by the F1F0-ATP synthase func-
tioning in reverse mode). In WT MEFs, this led to a rise of
[Ca2]i because of release of Ca2 from mitochondria. This
response was attenuated significantly in Drp1 C452F cells (Fig.
4, A and B), suggesting impaired mitochondrial uptake of Ca2
released from the ER after CPA treatment.
To directly measure themitochondrial calcium transient, we
transfected Drp1 WT and Drp1 C452F MEFs with a targeted
mitochondrial aequorin. The mitochondrial transient after
addition of ATP confirmed a significant reduction in mito-
chondrial calcium uptake in the mutant cells (Fig. 4C).
Next we assessed inositol 1,4,5-trisphosphate-mediated
release of [Ca2]i from intracellular stores by application of
ATP in the absence of extracellular Ca2 (Fig. 4,D and E). Basal
[Ca2]i was raised significantly in the C452F MEFs in both the
absence or presence of extracellular calcium. After application
of 0.1 mM ATP, the amplitude and duration of the C452F cal-
cium transient was significantly greater than that of the WT.
There was no effect on themagnitude of the subsequent capac-
itative Ca2 transient, which was similar to that of WT cells
(data not shown). In summary, these data show that Drp1
C452F is associated with significantly reduced mitochondrial
calcium uptake, a critical regulator of energy supply and
demand matching in the heart (28).
Cardiac Drp1 Dysfunction Leads to Inflammation—Failure
of cellular control over mitochondria leads to the activation of
innate immune signaling (29–31). In the heart, free mitochon-
drial DNA because of loss of DNase II has been shown to acti-
vate TLR9, resulting in heart failure in mice (9). We investi-
gated whether the failure of mitophagy observed in our cellular
model was associated with activation of inflammation in the
Python mouse heart. We measured the expression of pro-in-
flammatory genes encoding IL-6, TNF, and IFN in the hearts
of young animals (at 50 days of age) prior to the development of
cardiomyopathy (Fig. 5A) and old animals (150 days of age)with
incipient heart failure (Fig. 5B). In both young and old mouse
hearts, there was significant activation of the inflammatory cas-
FIGURE 3. A, mitochondria were analyzed from the hearts of Python C57BL/6J
mice after exposure to different conditions. Pyruvate, glutamate, andmalate
(Pyr/Mal/Glu) were added to initiate respiration. ADP and succinate are sub-
strates of ATP synthase and complex II, respectively. FCCP uncouples the
OXPHOS system, representing the maximum capacity of the electron trans-
port chain. Rotenone and antimycin A are inhibitors of complexes I and III,
respectively. General respiration begins to decline at 4 months of age. ATP
synthase activity gradually declines from 3months of age until onset of heart
failure. Complexes I and II both show no alteration of OXPHOS activity until 5
months of age, when a dramatic reduction becomes evident for both com-
plexes and remains the sameuntil theonset of overt heart failure at 6months.
Themaximumcapacity of the electron transport chain also follows adramatic
decline from 5months. Inhibition with antimycin A displays a gradual reduc-
tion from3months of age ( *,p 0.05, **,p 0.01). B,mitochondrial OXPHOS
activity in wild-type hearts. No significant decreases in O2 flux were observed
between any of the time points measured.
Mechanisms of Drp1 Cardiomyopathy
25914 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 290•NUMBER 43•OCTOBER 23, 2015
 at U
N
IV
ERSITY
 O
F LEED
S on N
ovem
ber 17, 2015
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
cade (Fig. 5B). This pattern of immune activation was not seen
in a controlmodel of heart failure induced in age-matchedmice
by transverse aortic constriction (TAC, Fig. 5B).
Induction of Autophagy by Low-protein Diet Rescues Cardiac
Failure—In light of defective mitochondrial recycling by
mitophagy, we sought to assess the therapeutic potential of
activating generalized cellular macroautophagy in the Python
model (32). Activation of autophagy by low protein diet (LPD)
has been shown previously to be beneficial in a model of con-
genital muscular dystrophy caused by abnormal autophagy,
leading to improved myofiber survival (33).
We commenced a cohort of mice on an isocaloric 6% LPD
from 4 weeks of age. The LPD led to activation of the macroau-
tophagy pathway, as demonstrated by an increased ratio of
LC3-I:LC3-II (Fig. 6A). At 150 days of age, mice underwent
echocardiography and were sacrificed. Compared with Python
littermates on a control chow diet, LPD animals were signifi-
cantly lighter and had a reduced heart weight to tibial length
ratio (Fig. 6, B and C). Echocardiography at 150 days of age
showed substantial improvements in the left ventricular end-
diastolic dimension and ejection fraction, although this was not
completely restored to normal (Fig. 6, C–F).
The improvement in cardiac function with LPD was not
associated with reduced expression of the inflammatory cyto-
kines IL-6, TNF, or IFN (data not shown) or a significant
change in the mitochondrial:nuclear DNA ratio (Fig. 6G), sug-
gesting that intactmitochondrialDNA is not the primary driver
of cardiomyopathy. These data show that activation of mac-
roautophagy by LPD leads to significant improvement in car-
diac function inPythonmice, albeit without an evident decrease
in mitochondrial copy number.
Discussion
We present the first model manifesting stabilization of Drp1
oligomers. Our data suggest that dysfunctional Drp1C452F has
multiple downstream cellular consequences driving DCM,
including inefficient mitophagy, impaired mitochondrial cal-
cium handling, deficient ATP biosynthesis, and inflammation.
In this setting, activation of macroautophagy by exposure to a
low-protein diet partially protects against DCM. Our results
FIGURE4.A, representative traces showing [Ca2]i inWT (top panel) andC452F (bottompanel)MEFs followingemptyingof ER storeswith the reversible ERCa
2
ATPase inhibitor CPA, followed by emptying of mitochondrial Ca2 stores using FCCP in the presence of oligomycin (Oligo). r.u., relative units. B, results
(mean S.E.) for the peak response to CPA and the peak response to FCCP and oligomycin inWT and C452FMEFs (n 10/group). Ab units, absorbance units.
*, p 0.05; ns, not significant. C, representative traces and area under the curve (AUC) of mitochondrial Ca2 uptake in MEFs (measured by mitochondrially
targeted aequorin) after ATP-evoked ER Ca2 release (n 2/group). *, p 0.05. D, representative traces of [Ca2]i during ATP-evoked Ca
2 release from ER
stores, followed by capacitative calcium entry inWT and C452FMEFs. 100MATPwas applied for the duration of the black bar to evoke Ca2 release from the
ER prior to reintroducing Ca2 (2.5 mM) in the perfusate to determine the capacitative calcium entry. E, results (mean  S.E.) for resting Ca2-containing
baseline, the peak response to ATP, the integral of the response (AUC), and the t1⁄2 inWT and C452FMEFs (n 12 recordings forWT and 11 for C452F). ***, p
0.01.
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provide support for the critical role of Drp1-mediated mito-
chondrial regulation and quality control in cardiacmetabolism.
Drp1 C452F protein function is abnormal, with supranormal
GTPase function but a failure of disassembly after oligomeriza-
tion. Although this is a novel finding for Drp1, there is a prec-
edent for the similar influence of middle-domain mutations in
the closely related human dynamin 2 gene, where disassembly
mutants have preserved GTPase function but are functionally
deficient, leading to congenital myopathy (34, 35).
Three recent studies have employed an inducible knock-
down approach to study the role of cardiac Drp1 (36–38). All
showed that loss of Drp1 leads to progressive heart failure but
with important differences in cellular pathogenesis. Ikeda et al.
(36) have found that inducible down-regulation of Drp1 leads
to reduced mitophagy with accumulation of damaged mito-
chondria. Kageyama et al. (38) have shown increased levels of
the mitophagy markers p62 and ubiquitin, consistent with
accelerated early mitophagy, but impaired delivery of mito-
chondria to lysosomes. Finally, Song et al. (37) have reported
abundant formation of mitophagosomes and decreased mito-
chondrial content, proposing a model of retained fission, but
inappropriate mitophagic degradation and generalized mito-
chondrial loss. A central feature of the studies by Ikeda et al.
(36) and Song et al. (37) was necrotic cell death by activation of
the mitochondrial permeability transition pore.
Collectively, this approach has established a critical role for
cardiac Drp1 in mitophagy/autophagy (39). However, in con-
trast to the inducible knockout approach, our model of a Drp1
missense mutation is functionally hypomorphic with substan-
tially retained protein activity. Impaired Drp1 depolymeriza-
tion may lead to futile GTP hydrolysis and Drp1 sequestration,
resulting in functional Drp1 haploinsufficiency. This may
explain the cardiac specificity of the Python phenotype. The
retained Drp1 activity is likely sufficient for other organs with
limitedmitochondrial remodeling, but the accelerated require-
ments of the heart become limiting over time, with an increas-
ing burden of mitochondrial dysfunction manifesting as DCM.
Our data should be viewed in this context of residual cellular
Drp1 activity. Unlike the inducible Drp1-KO, where heart fail-
ure develops in4–6weeks,Python undergoes a chronic accu-
mulation of defective, depolarized mitochondria, which per-
mits viability. The chronicity and long-term viability of our
model makes it likely to be of greater relevance to human
disease.
We propose that accumulation of damaged mitochondria
occurs through the relative failure of mitophagy. Although dif-
ficult to demonstrate directly in the heart, under conditions
of acute nutrient deprivation or bafilomycin exposure, we
observed reduced colocalization of the mature autophagosome
marker LC3 and mitochondrial pyruvate dehydrogenase; visu-
alization of numerous immature, fusedmitochondrial autopha-
gosomes; and reduced clearance of mitochondrial DNA after
nutrient deprivation. Our previous work has shown the accu-
mulation of mitochondrial DNA in the aging Python heart, also
consistent with a failure of completed mitophagy (3).
In the Python heart, we found evidence of activated innate
immune signaling, consistent with recent work demonstrating
that a failure of cellular control of mitochondria can result in
the activation of the inflammasome, Toll-like receptors, stimu-
lator of interferon genes (STING) and mitochondrial antiviral
signaling protein (MAVS) (31). Activation of cardiac inflamma-
tory nodes, specifically TLR9, influences mitochondrial cal-
FIGURE 5. A, quantitative PCR of inflammatory cytokines in young (age, 50 days) Python mice prior to the development of left ventricular dysfunction (n 
10/group). B, inflammatory cytokines in old (age, 150 days) Python mice, which display severe left ventricular dysfunction, compared with age-matched
littermateWTmice andage-matchedmicewith left ventricular failure inducedby transverse aortic constriction (TAC)mice (n9–11/group). *,p0.05; **,p
0.01; ***, p 0.001; ns, not significant.
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ciumby inhibition of SERCA2, reducingmitochondrial calcium
uptake and ATP synthesis (40). This has been interpreted as a
stress protection response in cardiomyocytes but might also be
detrimental when activated long-term, leading to functional
ATP deficiency. Our work in MEFs confirms reduced mito-
chondrial calcium uptake.
Drp1 C452F leads to profound ATP deficiency in MEFs and
the Python heart, supporting a wider body of work linking Drp1
with respiratory failure in both cell models and in the heart (36,
38, 41). In the Python heart, two models can be invoked to
explain energetic failure: first, a direct effect of reduced mito-
chondrial calcium uptake (occurring by inflammation-medi-
ated deactivation of SERCA2), leading to reduced stimulation
of OXPHOS, or, alternatively, through accumulation of a pool
of damaged, inefficient mitochondria. Therapeutic interven-
tion on the cardiac Drp1 pathway has so far focused on inhibi-
tion of fission in acute ischemia-reperfusion, but low-level
chronic activation to promote mitophagy and high ATP syn-
thesis might be of benefit in the failing heart (42, 43).
Although increasing autophagy normalized ventricular func-
tion, there was a less prominent effect on inflammation and
mitochondrial copy number. This likely reflects the presence of
multiple parallel drivers of inflammation downstream of failed
mitophagy, not all of which are resolved by intervention on the
macroautophagy pathway.
In this study, we analyzed the downstream consequences of a
Drp1 mutation underlying heart failure in mice. Drp1 has a
non-redundant role in cardiomyocyte mitophagy and, likely,
mitochondrial quality control in the heart. Although, as
inferred from our model, this is evident at baseline, it is likely
that the role of Drp1 is also manifest during diverse cardiac
stresses (36). We describe a model of mitophagic failure with
FIGURE 6. A, Western blot analysis for LC3 in Python cardiac samples demonstrating activation of macroautophagy by an isocaloric LPD. B and C, overall body
weight and ratio of heart weight to tibia length was significantly lower in the Python group on LPD (n	5/group) compared with Pythonmice on a normal
chow diet. ***, p  0.01 Python (Py)/LPD versus Py/chow. D, representative M mode echocardiography images performed at an age of 150 days, showing
improved cardiac function. E, LPD decreased left ventricular end-diastolic dimension (LVEDD). ***, p  0.01 Py/LPD versus Py/chow. F, improved ejection
fraction (EF). ***, p 0.01 Py/LPD versus Py/chow.G, the overall mitochondrial:nuclear DNA ratiowas unchanged by LPD, suggesting that intactmitochondrial
DNA is not the primary driver of cardiomyopathy.
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activation of inflammation and aberrant calcium handling
downstream. Importantly, our model does not make use of an
inducible knockout approach but demonstrates that dilated
cardiomyopathy can follow a single pathogenicmissensemuta-
tion in Drp1. As exemplified by Drp1 C452F in mice, key pro-
teins in the fission-fusion-mitophagy machinery are good can-
didates for familial DCM in humans.
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